ACE2 and cardiovascular disorder: Elevated levels of ACE2 and its activity are the biomarkers of cardiovascular disease including patients with heart failure [52], which indicate that these patients may be more susceptible to COVID-19 infection [53], with worsened prognosis of cardiovascular disease treatment [54].